BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12186348)

  • 1. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans.
    Sculean A; Chiantella GC; Windisch P; Gera I; Reich E
    Int J Periodontics Restorative Dent; 2002 Jun; 22(3):259-67. PubMed ID: 12186348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of intra-bony defects following treatment with a composite bovine-derived xenograft (Bio-Oss Collagen) in combination with a collagen membrane (Bio-Gide PERIO).
    Sculean A; Chiantella GC; Windisch P; Arweiler NB; Brecx M; Gera I
    J Clin Periodontol; 2005 Jul; 32(7):720-4. PubMed ID: 15966877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of bovine-derived xenografts and enamel matrix derivative in the treatment of intrabony periodontal defects in dogs.
    Yamamoto S; Masuda H; Shibukawa Y; Yamada S
    Int J Periodontics Restorative Dent; 2007 Oct; 27(5):471-9. PubMed ID: 17990444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft.
    Sculean A; Windisch P; Keglevich T; Chiantella GC; Gera I; Donos N
    Int J Periodontics Restorative Dent; 2003 Feb; 23(1):47-55. PubMed ID: 12617368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study.
    Sculean A; Pietruska M; Schwarz F; Willershausen B; Arweiler NB; Auschill TM
    J Clin Periodontol; 2005 Jan; 32(1):111-7. PubMed ID: 15642068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series.
    Schwarz F; Bieling K; Latz T; Nuesry E; Becker J
    J Clin Periodontol; 2006 Jul; 33(7):491-9. PubMed ID: 16820037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
    Döri F; Arweiler N; Gera I; Sculean A
    J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
    Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
    J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases.
    Sculean A; Reich E; Chiantella GC; Brecx M
    Int J Periodontics Restorative Dent; 1999 Apr; 19(2):157-63. PubMed ID: 10635181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human histologic evaluation of an intrabony defect treated with enamel matrix derivative, xenograft, and GTR.
    Sculean A; Windisch P; Chiantella GC
    Int J Periodontics Restorative Dent; 2004 Aug; 24(4):326-33. PubMed ID: 15446402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and radiological evaluation of DFDBA with amniotic membrane versus bovine derived xenograft with amniotic membrane in human periodontal grade II furcation defects.
    Kothiwale SV; Anuroopa P; Gajiwala AL
    Cell Tissue Bank; 2009 Nov; 10(4):317-26. PubMed ID: 19277899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Djordjevic M; Kenney EB
    J Periodontol; 2001 Sep; 72(9):1157-63. PubMed ID: 11577946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial.
    Hanna R; Trejo PM; Weltman RL
    J Periodontol; 2004 Dec; 75(12):1668-77. PubMed ID: 15732870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.